These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11161789)

  • 1. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).
    Sheng Z; He J; Tuppen JA; Sun W; Fazili Z; Smith ER; Dong FB; Xu XX
    Genomics; 2000 Dec; 70(3):381-6. PubMed ID: 11161789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
    Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
    Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells.
    Tseng CP; Huang CH; Tseng CC; Lin MH; Hsieh JT; Tseng CH
    Biochem Biophys Res Commun; 2001 Jul; 285(1):129-35. PubMed ID: 11437382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal location of murine disabled-2 gene and structural comparison with its human ortholog.
    Sheng Z; Smith ER; He J; Tuppen JA; Martin WD; Dong FB; Xu XX
    Gene; 2001 May; 268(1-2):31-9. PubMed ID: 11368898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
    Yang DH; Smith ER; Cohen C; Wu H; Patriotis C; Godwin AK; Hamilton TC; Xu XX
    Cancer; 2002 May; 94(9):2380-92. PubMed ID: 12015763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
    Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
    Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence, genomic structure, and chromosomal assignment of human DOC-2.
    Albertsen HM; Smith SA; Melis R; Williams B; Holik P; Stevens J; White R
    Genomics; 1996 Apr; 33(2):207-13. PubMed ID: 8660969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
    Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
    Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
    Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.
    Moran KM; Crusio RH; Chan CH; Grekova MC; Richert JR
    Gene; 2004 Oct; 341():235-47. PubMed ID: 15474306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
    Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
    Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
    Aoki K; Kato J; Shoemaker MT; Moss J
    Gene; 2005 May; 351():83-95. PubMed ID: 15893437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization and expression of mouse prestin, the motor protein of outer hair cells.
    Zheng J; Long KB; Matsuda KB; Madison LD; Ryan AD; Dallos PD
    Mamm Genome; 2003 Feb; 14(2):87-96. PubMed ID: 12584604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
    Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
    Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization and linkage via a bidirectional promoter of the AP-3 (adaptor protein-3) mu3A and AK (adenosine kinase) genes: deletion mutants of AK in Chinese hamster cells extend into the AP-3 mu3A gene.
    Singh B; Gupta RS
    Biochem J; 2004 Mar; 378(Pt 2):519-28. PubMed ID: 14575525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter.
    Hansen JJ; Bross P; Westergaard M; Nielsen MN; Eiberg H; Børglum AD; Mogensen J; Kristiansen K; Bolund L; Gregersen N
    Hum Genet; 2003 Jan; 112(1):71-7. PubMed ID: 12483302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic organization and functional characterization of the promoter for the human suppressor of cytokine signaling 6 gene.
    Lai RH; Wang MJ; Yang SH; Chen JY
    Gene; 2009 Dec; 448(1):64-73. PubMed ID: 19716864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.